-
液垂れを低減する点眼ノズルの形状の開発
藤本 高志、山口 正純、大久保 宏哉、高見 勇人
あたらしい眼科 40(12):1611~1616,2023©
-
アジマイシン点眼液1%の小児の結膜炎を対象とした特定使用成績調査
山際 智充、坂本 祐一郎、末信 敏秀
あたらしい眼科 40(11):1469~1475,2023©
-
Survey of toxicity study packages and designs of intravitreal drugs approved in Japan
Kotaro Yamada, Yoshinori Yamagiwa, Yu Haranosono
Fundamental Toxicological Sciences. 2023; 10(6): 249-258.
-
Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis
Eriko Kunikane1, Yusuke Orii2, Akiko Inoue1, Masaru Inatani2
1 Senju Pharmaceutical Co., Ltd.
2 University of Fukui
Ophthalmol Ther (2023). https://doi.org/10.1007/s40123-023-00794-x
-
New Candidate Preservative in Ophthalmic Solution Instead of Benzalkonium Chloride: 1,3-Didecyl-2-methyl Imidazolium Chloride
Takuya Iwasaki, Ryosuke Uchiyama, and Kazuto Nosaka
Chemical and Pharmaceutical Bulletin 71(7) 552–557, 2023
-
Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
Yusuke Orii1, Eriko Kunikane2, Yutaka Yamada1, Masakazu Morioka1, Kentaro Iwasaki1, Shogo Arimura1,Akemi Mizuno2 and Masaru Inatani1
1 Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan
2 Senju Pharmaceutical Co., Ltd., Osaka 541-0048, Japan
J. Clin. Med. 2023, 12, 4175. https://doi.org/10.3390/jcm12134175
-
A survey of on the use of genotoxicity and carcinogenicity testing packages for ophthalmic drug development
Haruna Tahara,Yu Haranosono
Fundamental Toxicological Sciences. 2023; 10(3): 105-112.
-
Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
Yasuo Yanagi1, Kanji Takahashi2, Tomohiro Iida3, Fumi Gomi4, Junko Morii5, Eriko Kunikane6, Taiji Sakamoto7
1 Department of Ophthalmology and Microtechnology, Yokohama City University, Kanagawa, Japan.
2 Department of Ophthalmology, Kansai Medical University, Osaka, Japan.
3 Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan.
4 Department of Ophthalmology, Hyogo Medical University, Hyogo, Japan.
5 IQVIA Solutions Japan, K.K., Tokyo, Japan.
6 Senju Pharmaceutical Co., Ltd., Osaka, Japan.
7 Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Ophthalmology and Therapy. 2023. doi:10.1007/s40123-023-00715-y.
-
点眼剤の製剤設計とそのポイント
山口正純
製剤の達人による製剤技術の伝承 製剤設計・製造技術 BASIC&FRONTIER, 429-442
-
薬物ナノ結晶製剤の眼内動態評価と眼疾患治療への応用性
増田 柊也1、長井 紀章2
1近畿大学薬学部(千寿製薬株式会社)
2近畿大学薬学部
(株)技術情報協会発刊書籍「新規モダリティ医薬品のための新しいDDS技術と製剤化」